The partners aim to develop AI-powered, real-time, personalized brain-computer interface therapies for neurological disorders ...

InBrain Neuroelectronics announced today that it entered into a strategic collaboration with Microsoft to explore AI in ...

Inbrain will apply Microsoft's agentic AI and cloud tech to its brain-computer interface, which could facilitate faster ...

A New York-based biotech firm announced it has raised an additional $200 million in financing to advance commercialization of ...

The funds are expected to accelerate commercialization of the company’s Stentrode BCI platform, while advancing development ...

Synchron Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in New York and San Diego The round was led by Double Point Ventures, alongside ...

Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giant’s Azure AI infrastructure to advance the Spanish ...

Viewed as the next evolution of artificial intelligence (AI), agentic AI enables systems to act autonomously based on ...

Learn about new materials and manufacturing processes for brain computer interfaces, heart valves and orthopedic implants.

Synchron announced today that it raised $200 million in a Series D financing round to support the commercialization of its ...

The growing adoption of BCI technology is attributable to its rising awareness in treating a wide range of brain disorders. The growing incidences of brain disorders, stroke, depression, and Parkinson ...

Brain-computer interface (BCI) technology creates a direct link between the brain’s electrical activity and a digital device. This connection can bring a vast range of benefits in assisting, ...